Trials / Completed
CompletedNCT04114240
French Study in Real Life Evaluating Xybilun
French Study in Real Life Evaluating Xybilun: Convenience and Erection Induction Related to a New Administration in Orodispersible Film
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 105 (actual)
- Sponsor
- Laboratoires Genévrier · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Collecting Xybilun (Viagra's generic) efficacity, tolerance, convenience and patients/doctors satisfaction's data at different doses (50-75-100 mg), is the aim of the study.
Detailed description
Study design Population Patients without prior treatment with a first Xybilun prescription Patients already treated for who the treatment is remplaced by Xybilun Study perimeter 400 patients 50 investigators (sexologists, urologists)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Xybilun | Erectil dysfunction, Viagra generic (sildénafil) |
Timeline
- Start date
- 2018-05-23
- Primary completion
- 2019-04-26
- Completion
- 2019-04-26
- First posted
- 2019-10-03
- Last updated
- 2019-10-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04114240. Inclusion in this directory is not an endorsement.